MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3 Retraction in /10.3892/ijo.2023.5515

Zhang,Shufang; Zhang,Chong; Liu,Wei; Zheng,Wenwen; Zhang,Yingai; Wang,Shunlan; Huang,Denggao; Liu,Xi; Bai,Zhiming

doi:10.3892/ijo.2015.3117

MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3

Retraction in 10.3892/ijo.2023.5515

Authors:
- Shufang Zhang
- Chong Zhang
- Wei Liu
- Wenwen Zheng
- Yingai Zhang
- Shunlan Wang
- Denggao Huang
- Xi Liu
- Zhiming Bai
View Affiliations

Affiliations: Central Laboratory, Affiliated Haikou Hospital, Xiangya School of Medicine Central South University, Haikou Municipal People's Hospital, Haikou 570208, P.R. China, Department of Urology, Affiliated Haikou Hospital, Xiangya School of Medicine Central South University, Haikou Municipal People's Hospital, Haikou 570208, P.R. China, Clinical Laboratory, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, P.R. China
Published online on: August 7, 2015 https://doi.org/10.3892/ijo.2015.3117
Pages: 1351-1360

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Increasing evidence has confirmed that dysregulation of microRNAs (miRNAs) can contribute to the progression and metastasis of human tumors. Previous studied have shown dysregulation of miR-24 in a variety of tumors. However, the roles of miR-24 in human bladder cancer have not been well clarified. Therefore, we investigated the biological functions and molecular mechanisms of miR-24 in human bladder cancer cell lines, evaluating whether it could be a therapeutic biomarker of bladder cancer in the future. In our study, we found that miR-24 is downregulated in human bladder cancer cell lines. Moreover, the low level of miR-24 was associated with increased expression of CARMA3 in bladder cancer cells. Upregulation of miR-24 significantly inhibited proliferation, arrested cell cycle and induced apoptosis in bladder cancer cells. In addition, invasion and epithelial to mesenchymal transition (EMT) of bladder cancer cells was suppressed by overexpressing miR-24. Bioinformatics analysis predicted that the CARMA3 was a potential target gene of miR-24. Further study by luciferase reporter assay demonstrated that miR-24 could directly target CARMA3. Overexpression of CARMA3 in bladder cancer cells transfected with miR-24 mimic partially reversed the inhibitory effect of miR-24. In conclusion, miR-24 inhibited cell proliferation, invasion and EMT in bladder cancer cells by downregulation of CARMA3, and that downregulation of CARMA3 was essential for the miR-24-inhibited cell proliferation, invasion and EMT in bladder cancer cells.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	Amling CL: Diagnosis and management of superficial bladder cancer. Curr Probl Cancer. 25:219–278. 2001. View Article : Google Scholar : PubMed/NCBI
3	Bulbul MA, Husseini N and Houjaij A: Superficial bladder cancer epidemiology, diagnosis and management. J Med Liban. 53:107–113. 2005.
4	Zuiverloon TC, Nieuweboer AJ, Vekony H, Kirkels WJ, Bangma CH and Zwarthoff EC: Markers predicting response to bacillus Calmette Guerin immunotherapy in high-risk bladder cancer patients: a systematic review. Eur Urol. 61:128–145. 2012. View Article : Google Scholar
5	Vinall RL, Ripoll AZ, Wang S, Pan CX and deVere White RW: MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status. Int J Cancer. 130:2526–2538. 2012. View Article : Google Scholar
6	Luke C, Tracey E, Stapleton A and Roder D: Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control. Intern Med J. 40:357–362. 2010. View Article : Google Scholar
7	Jiang QQ, Liu B and Yuan T: MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1. Asian Pac J Cancer Prev. 14:4127–4130. 2013. View Article : Google Scholar : PubMed/NCBI
8	Bellmunt J and Petrylak DP: New therapeutic challenges in advanced bladder cancer. Semin Oncol. 39:598–607. 2012. View Article : Google Scholar : PubMed/NCBI
9	Bartel DP: Micrornas: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
10	Kim VN, Han J and Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009. View Article : Google Scholar : PubMed/NCBI
11	Thomson DW, Bracken CP and Goodall GJ: Experimental strategies for microRNA target identification. Nucleic Acids Res. 39:6845–6853. 2011. View Article : Google Scholar : PubMed/NCBI
12	Wiemer EA: The role of microRNAs in cancer: no small matter. Eur J Cancer. 43:1529–1544. 2007. View Article : Google Scholar : PubMed/NCBI
13	Andrew AS, Marsit CJ, Schned AR, Seigne JD, Kelsey KT, Moore JH, Perreard L, Karagas MR and Sempere LF: Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence. Int J Cancer. Dec 29–2014.(Epub ahead of print). View Article : Google Scholar
14	Zhang T, Wang J, Zhai X, Li H, Li C and Chang J: MiR-124 retards bladder cancer growth by directly targeting CDK4. Acta Biochim Biophys Sin (Shanghai). 46:1072–1079. 2014. View Article : Google Scholar
15	Wang X, Wu J, Lin Y, Zhu Y, Xu X, Xu X, Liang Z, Li S, Hu Z, Zheng X and Xie L: MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6. J Exp Clin Cancer Res. 33:692014. View Article : Google Scholar : PubMed/NCBI
16	Zeng T, Peng L, Chao C, Fu B, Wang G, Wang Y and Zhu X: miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Int J Clin Exp Pathol. 7:7653–7662. 2014.
17	Liang Z, Li S, Xu X, Xu X, Wang X, Wu J, Zhu Y, Hu Z, Lin Y, Mao Y, et al: MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. Mol Cells. 38:130–137. 2015. View Article : Google Scholar : PubMed/NCBI
18	Feng Y, Liu J, Kang Y, He Y, Liang B, Yang P and Yu Z: miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer. J Exp Clin Cancer Res. 33:672014. View Article : Google Scholar : PubMed/NCBI
19	Xiu Y, Liu Z, Xia S, Jin C, Yin H, Zhao W and Wu Q: MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3. PLoS One. 9:e1097342014. View Article : Google Scholar : PubMed/NCBI
20	Zhang DQ, Zhou CK, Jiang XW, Chen J and Shi BK: Increased expression of miR-222 is associated with poor prognosis in bladder cancer. World J Surg Oncol. 12:2412014. View Article : Google Scholar : PubMed/NCBI
21	Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu Y, Li C, Su L, Zhu Z, Xiang M, Liu B and Yang Q: Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer. 13:1272014. View Article : Google Scholar : PubMed/NCBI
22	Song L, Yang J, Duan P, Xu J, Luo X, Luo F, Zhang Z, Hou T, Liu B and Zhou Q: MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ. Arch Biochem Biophys. 535:128–135. 2013. View Article : Google Scholar : PubMed/NCBI
23	Yin JY, Deng ZQ, Liu FQ, Qian J, Lin J, Tang Q, Wen XM, Zhou JD, Zhang YY and Zhu XW: Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer. Int J Clin Exp Pathol. 7:4261–4267. 2014.PubMed/NCBI
24	Liu YX, Long XD, Xi ZF, Ma Y, Huang XY, Yao JG, Wang C, Xing TY and Xia Q: MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. Biomed Res Int. 2014:4829262014.PubMed/NCBI
25	Blonska M and Lin X: NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res. 21:55–70. 2010. View Article : Google Scholar
26	Wang L, Guo Y, Huang WJ, Ke X, Poyet JL, Manji GA, Merriam S, Glucksmann MA, DiStefano PS, Alnemri ES and Bertin J: Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem. 276:21405–21409. 2001. View Article : Google Scholar : PubMed/NCBI
27	Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M and Keshavarzian A: PKC-beta1 isoform activation is required for EGF-induced NF-kappaB inactivation and IkappaBalpha stabilization and protection of F-actin assembly and barrier function in enterocytemonolayers. Am J Physiol Cell Physiol. 286:C723–C738. 2004. View Article : Google Scholar
28	McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, Kim DS, Kuffa P, Kohrt D, Mak TW, Nuñez G and Lucas PC: CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA. 104:139–144. 2007. View Article : Google Scholar
29	Grabiner BC, Blonska M, Lin PC, You Y, Wang D, Sun J, Darnay BG, Dong C and Lin X: CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-κB activation. Genes Dev. 21:984–996. 2007. View Article : Google Scholar : PubMed/NCBI
30	Wang D, You Y, Lin PC, Xue L, Morris SW, Zeng H, Wen R and Lin X: Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc Natl Acad Sci USA. 104:145–150. 2007. View Article : Google Scholar
31	Wu GL, Yuan JL, Huang XD, Rong JF, Zhang LX, Liu YP and Wang FL: Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma. Tumour Biol. 34:3431–3435. 2013. View Article : Google Scholar : PubMed/NCBI
32	Zhao T, Miao Z, Wang Z, Xu Y, Wu J, Liu X, You Y and Li J: CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells. Tumour Biol. 34:3041–3047. 2013. View Article : Google Scholar : PubMed/NCBI
33	Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J and Xu H: CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression. Biochem Biophys Res Commun. 425:781–787. 2012. View Article : Google Scholar : PubMed/NCBI
34	Man X, He J, Kong C, Zhu Y and Zhang Z: Clinical significance and biological roles of CARMA3 in human bladder carcinoma. Tumour Biol. 35:4131–4136. 2014. View Article : Google Scholar : PubMed/NCBI
35	Jiang T, Grabiner B, Zhu Y, Jiang C, Li H, You Y, Lang J, Hung MC and Lin X: CARMA3 is crucial for EGFR-Induced activation of NF-kappaB and tumor progression. Cancer Res. 71:2183–2192. 2011. View Article : Google Scholar : PubMed/NCBI
36	Borthakur A, Bhattacharyya S, Alrefai WA, Tobacman JK, Ramaswamy K and Dudeja PK: Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm Bowel Dis. 16:593–603. 2010. View Article : Google Scholar
37	Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J and Sung JJ: MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
38	Miao J, Wu S, Peng Z, Tania M and Zhang C: MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
39	Yin J, Lin J, Luo X, Chen Y, Li Z, Ma G and Li K: miR-137: a new player in schizophrenia. Int J Mol Sci. 15:3262–3271. 2014. View Article : Google Scholar : PubMed/NCBI
40	Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med. 10:789–799. 2004. View Article : Google Scholar : PubMed/NCBI
41	Nevins JR: The Rb/E2F pathway and cancer. Hum Mol Genet. 10:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
42	Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan J and Wang L: The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol. 32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
43	Korbakis D and Scorilas A: Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumour Biol. 33:865–875. 2012. View Article : Google Scholar : PubMed/NCBI
44	Li Z, Qu L, Dong Q, Huang B, Li H, Tang Z, Xu Y, Luo W, Liu L, Qiu X and Wang E: Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One. 7:e369032012. View Article : Google Scholar : PubMed/NCBI
45	Du S, Jia L, Zhang Y, Fang L, Zhang X and Fan Y: CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion. Tumour Biol. 35:5965–5970. 2014. View Article : Google Scholar : PubMed/NCBI